A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis

Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is a rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasero, Daniela, Sanna, Silvana, Liperi, Corrado, Piredda, Davide, Branca, Gian Pietro, Casadio, Lorenzo, Simeo, Raffaella, Buselli, Alice, Rizzo, Davide, Bussu, Francesco, Rubino, Salvatore, Terragni, Pierpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745708/
https://www.ncbi.nlm.nih.gov/pubmed/33331988
http://dx.doi.org/10.1007/s15010-020-01561-x
Descripción
Sumario:Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is a rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case of a patient diagnosed with coronavirus disease (COVID-19) who developed a pulmonary mucormycosis with extensive cavitary lesions is here reported. This case highlights how this new coronavirus might impair the immune response, exposing patients to higher risk of developing opportunistic infections and leading to worse outcomes.

Ejemplares similares